查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1790223

用于早期癌症检测和监测的液态切片市场规模、份额和趋势分析报告：按生物标记、技术、癌症类型、最终用途、地区和细分市场预测，2025 年至 2033 年

Liquid Biopsy For Early Cancer Detection And Monitoring Market Size, Share & Trends Analysis Report By Biomarker (Circulating Tumor DNA, Circulating Tumor Cells ), By Technology, By Cancer, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 136 Pages | 商品交期: 2-10个工作天内

价格

早期癌症检测和监测的液态切片市场概述

用于早期癌症检测和监测的液态切片的全球市场规模预计在 2024 年为 22.3 亿美元，预计到 2033 年将达到 62 亿美元，2025 年至 2033 年的复合年增长率为 12.14%。该市场专注于旨在早期和准确检测各种癌症的诊断解决方案，从而能够及时干预并改善患者的治疗效果。

该领域的技术包括分析体液中循环肿瘤DNA (ctDNA)、循环性肿瘤细胞(CTC) 和其他生物标记的平台，为组织活体组织切片提供了侵入性更低的替代方案。这些解决方案正越来越多地被整合到临床和研究领域的肿瘤学实践中，用于早期检测、治疗方法选择和疾病监测。

液态切片的普及源于癌症发生率的上升，以及对能够频繁监测且最大程度减少患者不适的无创技术日益增长的需求。即时检测肿瘤相关基因变异的能力为肿瘤学家提供了宝贵的信息，可用于制定治疗决策和早期疗育策略。

此外，随着液态切片的应用也日益广泛，基因组学和分子学见解可为治疗决策和纵向护理提供资讯。由新一代定序、数位PCR工作流程和不断发展的生物资讯工具支援的高灵敏度技术正在帮助检测低频突变、微量残存疾病和新出现的抗药性讯号。此外，多癌种早期检测和检测试剂盒（可分析多种生物标记物，包括DNA、RNA片段、表观遗传特征和细胞外囊泡内容物）的研发，正在将临床应用从晚期管理扩展到风险评估和人群筛检。

此外，市场正受到实证项目、监管支援和支付方评估的影响，这些评估着重于与传统组织学方法相比的临床价值和成本效益。挑战依然存在，包括不同平台的检测性能差异、样本收集和分析缺乏标准化，以及难以解读早期疾病中的微弱讯号。某些地区的报销有限也影响了液体活检的可及性。正在进行的临床试验、真实世界试验和数据共用工作预计将提供更清晰的指导方针，改进指南，并推动液态切片在早期检测和持续癌症监测中的更广泛应用。

用于早期检测和监测的液态切片的创新强调准确性、可及性和临床适用性：多组体学整合、人工智慧主导的解释和先进的测序正在改变检测和追踪过程，从而提高对早期疾病的敏感性并提供更加个性化的治疗计划。

多癌种检测和近患者平台等发展旨在将液态切片扩展到集中式设施之外，从而提高便利性并支持大规模筛检倡议。微量残存疾病检测和持续监测的进展有望促进液态切片在临床上的更广泛应用，并加强其在癌症治疗中的作用。

目录

第一章 早期癌症检测和监测的液态切片市场：调查方法和范围

2. 早期癌症检测和监测的液态切片市场：执行摘要

  • 市场概述
  • 生物标誌物和技术简介
  • 癌症简介
  • 最终用途简介
  • 竞争格局简介

3.液态切片市场变数、趋势和早期癌症检测与监测范围

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
  • 市场驱动因素分析
    • 非侵入性癌症检测的需求不断增加
    • 先进技术的融合
    • 提高临床采用率和监管核准
  • 市场限制因素分析
    • 液态切片检测和基础设施高成本
    • 分析和临床检验的挑战
  • 波特五力分析
  • PESTLE分析
  • 管道分析

第四章 早期癌症检测和监测的液态切片市场：生物标记的估计和趋势分析

  • 早期癌症检测和监测的液态切片市场：生物标记变异分析
  • 循环肿瘤DNA（CtDNA）
  • 循环性肿瘤细胞（CTC）
  • 外泌体/微泡
  • 循环蛋白

第五章 早期癌症检测和监测的液态切片市场：技术评估和趋势分析

  • 早期癌症检测和监测的液态切片市场：技术变革分析
  • NGS（次世代定序）
  • 基于PCR的检测（数位PCR、RT-PCR）
  • 微阵列
  • 表观基因/甲基化分析
  • 其他的

第六章。早期癌症检测和监测的液态切片市场：按癌症类型、估计和趋势分析

  • 早期癌症检测和监测的液态切片市场：癌症变异分析
  • 肺癌
  • 乳癌
  • 大肠直肠癌
  • 摄护腺癌
  • 其他的

7. 早期癌症检测和监测液态切片市场（按最终用途、估值和趋势分析）

  • 早期癌症检测和监测的液态切片市场：最终用途变异分析
  • 医院
  • 诊断实验室
  • 其他的

8. 早期癌症检测和监测液态切片市场：区域业务分析

  • 区域市场概况
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

第九章 竞争态势

  • 公司分类
  • 战略地图
    • 推出新的生物标誌物
    • 伙伴关係
    • 获得
    • 合作
    • 资金筹措
  • 主要企业市场占有率分析（2024年）
  • 公司热图分析
  • 公司简介
    • Grail, Inc.
    • Exact Sciences Corporation
    • Anchordx
    • Burning Rock BIoTech Limited
    • Genecast
    • Guardant Health
    • Myriad Genetics, Inc.
    • Elypta Ab
    • Lucence Health Inc.
    • Freenome Holdings, Inc.
    • Oncimmune
Product Code: GVR-4-68040-683-3

Liquid Biopsy For Early Cancer Detection And Monitoring Market Summary

The global liquid biopsy for early cancer detection and monitoring market size was estimated at USD 2.23 billion in 2024 and is projected to reach USD 6.20 billion by 2033, growing at a CAGR of 12.14% from 2025 to 2033. This market focuses on diagnostic solutions designed for the early and accurate detection of various cancers, enabling timely intervention and improved patient outcomes.

Technologies within this segment include platforms for analyzing circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and other biomarkers from body fluids, offering a less invasive alternative to tissue biopsies. These solutions are increasingly integrated into oncology practices for early detection, therapy selection, and disease monitoring across clinical and research environments.

The adoption of liquid biopsy is supported by rising cancer incidence and the growing need for non-invasive methods that allow frequent monitoring with minimal discomfort to patients. The ability to detect tumor-related genetic changes in real time provides oncologists with valuable information for treatment decisions and early intervention strategies.

Moreover, the adoption of liquid biopsy is increasing as the field moves toward precision oncology, where genomic and molecular insights inform treatment decisions and long-term care. High-sensitivity techniques supported by next-generation sequencing, digital PCR workflows, and advancing bioinformatics tools help detect low-frequency variants, minimal residual disease, and emerging resistance signals. Additionally, efforts in multi-cancer early detection and assay panels that analyze multiple biomarkers such as DNA, RNA fragments, epigenetic signatures, and extracellular vesicle content are broadening clinical applications from late-stage management to risk assessment and population-level screening.

Furthermore, the market is shaped by evidence-generation programs, regulatory support, and payer assessments that focus on clinical value and cost-effectiveness compared to traditional tissue-based methods. Challenges still exist, such as variations in assay performance across platforms, a lack of standardization in sample collection and analysis, and difficulties in interpreting weak signals in early disease stages. Limited reimbursement in some regions also impacts accessibility. Ongoing clinical trials, real-world studies, and data-sharing initiatives are expected to bring clarity, improve guidelines, and promote wider adoption of liquid biopsy for early detection and continuous cancer monitoring.

Innovation in liquid biopsy for early detection and monitoring emphasizes accuracy, accessibility, and clinical applicability. Multi-omics integration, AI-driven interpretation, and advanced sequencing transform detection and tracking processes, enabling higher sensitivity for early-stage disease and more personalized treatment planning.

Developments such as multi-cancer detection assays and near-patient platforms aim to extend liquid biopsies outside centralized facilities, enhancing convenience and supporting large-scale screening initiatives. Progress in minimal residual disease detection and continuous monitoring is expected to drive broader clinical uptake and strengthen liquid biopsy's role in oncology care.

Global Liquid Biopsy For Early Cancer Detection And Monitoring Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global liquid biopsy for early cancer detection and monitoring market based on biomarker, technology, cancer, end use, and region:

  • Biomarker Outlook (USD Million; 2021 - 2033)
  • Circulating Tumor DNA (ctDNA)
  • Circulating Tumor Cells (CTCs)
  • Exosomes/Microvesicles
  • Circulating Proteins
  • Technology Outlook (USD Million; 2021 - 2033)
  • NGS (Next-Generation Sequencing)
  • PCR-based assays (Digital PCR, RT-PCR)
  • Microarray
  • Epigenomics / Methylation assays
  • Others
  • Cancer Outlook (USD Million; 2021 - 2033)
  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Others
  • End Use Outlook (USD Million; 2021 - 2033)
  • Hospitals
  • Diagnostic Laboratories
  • Others
  • Regional Outlook (USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Liquid Biopsy For Early Cancer Detection And Monitoring Market: Methodology And Scope

  • 1.1. Market Segmentation And Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Biomarker Segment
      • 1.1.1.2. Technology Segment
      • 1.1.1.3. Cancer Segment
      • 1.1.1.4. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates And Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. Gvr's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information Or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List Of Secondary Sources
  • 1.11. List Of Abbreviations

Chapter 2. Liquid Biopsy For Early Cancer Detection And Monitoring Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Biomarker And Technology Snapshot
  • 2.3. Cancer Snapshot
  • 2.4. End Use Snapshot
  • 2.5. Competitive Landscape Snapshot

Chapter 3. Liquid Biopsy For Early Cancer Detection And Monitoring Market Variables, Trends, & Scope

  • 3.1. Market Segmentation And Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Growing Demand For Non-Invasive Cancer Screening
    • 3.4.2. Integration Of Advanced Technologies
    • 3.4.3. Increasing Clinical Adoption And Regulatory Approvals
  • 3.5. Market Restraint Analysis
    • 3.5.1. High Cost Of Liquid Biopsy Tests And Infrastructure
    • 3.5.2. Analytical And Clinical Validation Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. Pestle Analysis
  • 3.8. Pipeline Analysis

Chapter 4. Liquid Biopsy For Early Cancer Detection And Monitoring Market: Biomarker Estimates & Trend Analysis

  • 4.1. Liquid Biopsy For Early Cancer Detection And Monitoring Market: Biomarker Movement Analysis
  • 4.2. Circulating Tumor Dna (Ctdna)
    • 4.2.1. Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 4.3. Circulating Tumor Cells (Ctcs)
    • 4.3.1. Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Exosomes/Microvesicles
    • 4.4.1. Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Circulating Proteins
    • 4.5.1. Market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Liquid Biopsy For Early Cancer Detection And Monitoring Market: Technology Estimates & Trend Analysis

  • 5.1. Liquid Biopsy For Early Cancer Detection And Monitoring Market: Technology Movement Analysis
  • 5.2. Ngs (Next-Generation Sequencing)
    • 5.2.1. Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 5.3. Pcr-Based Assays (Digital Pcr, Rt-Pcr)
    • 5.3.1. Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Microarray
    • 5.4.1. Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Epigenomics / Methylation Assays
    • 5.5.1. Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Others
    • 5.6.1. Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Liquid Biopsy For Early Cancer Detection And Monitoring Market: Cancer Estimates & Trend Analysis

  • 6.1. Liquid Biopsy For Early Cancer Detection And Monitoring Market: Cancer Movement Analysis
  • 6.2. Lung Cancer
    • 6.2.1. Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 6.3. Breast Cancer
    • 6.3.1. Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Colorectal Cancer
    • 6.4.1. Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Prostate Cancer
    • 6.5.1. Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Liquid Biopsy For Early Cancer Detection And Monitoring Market: End Use Estimates & Trend Analysis

  • 7.1. Liquid Biopsy For Early Cancer Detection And Monitoring Market: End Use Movement Analysis
  • 7.2. Hospitals
    • 7.2.1. Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.3. Diagnostic Laboratories
    • 7.3.1. Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Others
    • 7.4.1. Market Revenue Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Liquid Biopsy For Early Cancer Detection And Monitoring Market: Regional Business Analysis

  • 8.1. Regional Market Snapshot
  • 8.2. North America
    • 8.2.1. North America Liquid Biopsy For Early Cancer Detection And Monitoring Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Liquid Biopsy For Early Cancer Detection And Monitoring Market, 2021 - 2033 (USD Million)
      • 8.2.2.2. Key Country Dynamics
      • 8.2.2.3. Regulatory Framework
      • 8.2.2.4. Reimbursement Scenario
      • 8.2.2.5. Competitive Scenario
    • 8.2.3. Canada
      • 8.2.3.1. Canada Liquid Biopsy For Early Cancer Detection And Monitoring Market, 2021 - 2033 (USD Million)
      • 8.2.3.2. Key Country Dynamics
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. Reimbursement Scenario
      • 8.2.3.5. Competitive Scenario
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Liquid Biopsy For Early Cancer Detection And Monitoring Market, 2021 - 2033 (USD Million)
      • 8.2.4.2. Key Country Dynamics
      • 8.2.4.3. Regulatory Framework
      • 8.2.4.4. Reimbursement Scenario
      • 8.2.4.5. Competitive Scenario
  • 8.3. Europe
    • 8.3.1. Europe Liquid Biopsy For Early Cancer Detection And Monitoring Market, 2021 - 2033 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK Liquid Biopsy For Early Cancer Detection And Monitoring Market, 2021 - 2033 (USD Million)
      • 8.3.2.2. Key Country Dynamics
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. Reimbursement Scenario
      • 8.3.2.5. Competitive Scenario
    • 8.3.3. Germany
      • 8.3.3.1. Germany Liquid Biopsy For Early Cancer Detection And Monitoring Market, 2021 - 2033 (USD Million)
      • 8.3.3.2. Key Country Dynamics
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Reimbursement Scenario
      • 8.3.3.5. Competitive Scenario
    • 8.3.4. Spain
      • 8.3.4.1. Spain Liquid Biopsy For Early Cancer Detection And Monitoring Market, 2021 - 2033 (USD Million)
      • 8.3.4.2. Key Country Dynamics
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Reimbursement Scenario
      • 8.3.4.5. Competitive Scenario
    • 8.3.5. France
      • 8.3.5.1. France Liquid Biopsy For Early Cancer Detection And Monitoring Market, 2021 - 2033 (USD Million)
      • 8.3.5.2. Key Country Dynamics
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. Reimbursement Scenario
      • 8.3.5.5. Competitive Scenario
    • 8.3.6. Italy
      • 8.3.6.1. Italy Liquid Biopsy For Early Cancer Detection And Monitoring Market, 2021 - 2033 (USD Million)
      • 8.3.6.2. Key Country Dynamics
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Reimbursement Scenario
      • 8.3.6.5. Competitive Scenario
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark Liquid Biopsy For Early Cancer Detection And Monitoring Market, 2021 - 2033 (USD Million)
      • 8.3.7.2. Key Country Dynamics
      • 8.3.7.3. Regulatory Framework
      • 8.3.7.4. Reimbursement Scenario
      • 8.3.7.5. Competitive Scenario
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden Liquid Biopsy For Early Cancer Detection And Monitoring Market, 2021 - 2033 (USD Million)
      • 8.3.8.2. Key Country Dynamics
      • 8.3.8.3. Regulatory Framework
      • 8.3.8.4. Reimbursement Scenario
      • 8.3.8.5. Competitive Scenario
    • 8.3.9. Norway
      • 8.3.9.1. Norway Liquid Biopsy For Early Cancer Detection And Monitoring Market, 2021 - 2033 (USD Million)
      • 8.3.9.2. Key Country Dynamics
      • 8.3.9.3. Regulatory Framework
      • 8.3.9.4. Reimbursement Scenario
      • 8.3.9.5. Competitive Scenario
  • 8.4. Asia Pacific
    • 8.4.1. Asia-Pacific Liquid Biopsy For Early Cancer Detection And Monitoring Market, 2021 - 2033 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan Liquid Biopsy For Early Cancer Detection And Monitoring Market, 2021 - 2033 (USD Million)
      • 8.4.2.2. Key Country Dynamics
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Reimbursement Scenario
      • 8.4.2.5. Competitive Scenario
    • 8.4.3. China
      • 8.4.3.1. China Liquid Biopsy For Early Cancer Detection And Monitoring Market, 2021 - 2033 (USD Million)
      • 8.4.3.2. Key Country Dynamics
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Reimbursement Scenario
      • 8.4.3.5. Competitive Scenario
    • 8.4.4. India
      • 8.4.4.1. India Liquid Biopsy For Early Cancer Detection And Monitoring Market, 2021 - 2033 (USD Million)
      • 8.4.4.2. Key Country Dynamics
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Reimbursement Scenario
      • 8.4.4.5. Competitive Scenario
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea Liquid Biopsy For Early Cancer Detection And Monitoring Market, 2021 - 2033 (USD Million)
      • 8.4.5.2. Key Country Dynamics
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Reimbursement Scenario
      • 8.4.5.5. Competitive Scenario
    • 8.4.6. Thailand
      • 8.4.6.1. Thailand Liquid Biopsy For Early Cancer Detection And Monitoring Market, 2021 - 2033 (USD Million)
      • 8.4.6.2. Key Country Dynamics
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Reimbursement Scenario
      • 8.4.6.5. Competitive Scenario
    • 8.4.7. Australia
      • 8.4.7.1. Australia Liquid Biopsy For Early Cancer Detection And Monitoring Market, 2021 - 2033 (USD Million)
      • 8.4.7.2. Key Country Dynamics
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Reimbursement Scenario
      • 8.4.7.5. Competitive Scenario
  • 8.5. Latin America
    • 8.5.1. Latin America Liquid Biopsy For Early Cancer Detection And Monitoring Market, 2021 - 2033 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Liquid Biopsy For Early Cancer Detection And Monitoring Market, 2021 - 2033 (USD Million)
      • 8.5.2.2. Key Country Dynamics
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Reimbursement Scenario
      • 8.5.2.5. Competitive Scenario
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina Liquid Biopsy For Early Cancer Detection And Monitoring Market, 2021 - 2033 (USD Million)
      • 8.5.3.2. Key Country Dynamics
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Reimbursement Scenario
      • 8.5.3.5. Competitive Scenario
  • 8.6. MEA
    • 8.6.1. MEA Liquid Biopsy For Early Cancer Detection And Monitoring Market, 2021 - 2033 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa Liquid Biopsy For Early Cancer Detection And Monitoring Market, 2021 - 2033 (USD Million)
      • 8.6.2.2. Key Country Dynamics
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Reimbursement Scenario
      • 8.6.2.5. Competitive Scenario
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Saudi Arabia Liquid Biopsy For Early Cancer Detection And Monitoring Market, 2021 - 2033 (USD Million)
      • 8.6.3.2. Key Country Dynamics
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Reimbursement Scenario
      • 8.6.3.5. Competitive Scenario
    • 8.6.4. UAE
      • 8.6.4.1. UAE Liquid Biopsy For Early Cancer Detection And Monitoring Market, 2021 - 2033 (USD Million)
      • 8.6.4.2. Key Country Dynamics
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Reimbursement Scenario
      • 8.6.4.5. Competitive Scenario
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait Liquid Biopsy For Early Cancer Detection And Monitoring Market, 2021 - 2033 (USD Million)
      • 8.6.5.2. Key Country Dynamics
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Reimbursement Scenario
      • 8.6.5.5. Competitive Scenario

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
    • 9.2.1. New Biomarker Launch
    • 9.2.2. Partnerships
    • 9.2.3. Acquisition
    • 9.2.4. Collaboration
    • 9.2.5. Funding
  • 9.3. Key Company Market Share Analysis, 2024
  • 9.4. Company Heat Map Analysis
  • 9.5. Company Profiles
    • 9.5.1. Grail, Inc.
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Biomarker Benchmarking
      • 9.5.1.4. Strategic Initiatives
    • 9.5.2. Exact Sciences Corporation
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Biomarker Benchmarking
      • 9.5.2.4. Strategic Initiatives
    • 9.5.3. Anchordx
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Biomarker Benchmarking
      • 9.5.3.4. Strategic Initiatives
    • 9.5.4. Burning Rock Biotech Limited
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Biomarker Benchmarking
      • 9.5.4.4. Strategic Initiatives
    • 9.5.5. Genecast
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Biomarker Benchmarking
      • 9.5.5.4. Strategic Initiatives
    • 9.5.6. Guardant Health
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Biomarker Benchmarking
      • 9.5.6.4. Strategic Initiatives
    • 9.5.7. Myriad Genetics, Inc.
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Biomarker Benchmarking
      • 9.5.7.4. Strategic Initiatives
    • 9.5.8. Elypta Ab
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Biomarker Benchmarking
      • 9.5.8.4. Strategic Initiatives
    • 9.5.9. Lucence Health Inc.
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Biomarker Benchmarking
      • 9.5.9.4. Strategic Initiatives
    • 9.5.10. Freenome Holdings, Inc.
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Financial Performance
      • 9.5.10.3. Biomarker Benchmarking
      • 9.5.10.4. Strategic Initiatives
    • 9.5.11. Oncimmune
      • 9.5.11.1. Company Overview
      • 9.5.11.2. Financial Performance
      • 9.5.11.3. Biomarker Benchmarking
      • 9.5.11.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global liquid biopsy for early cancer detection and monitoring market, by region, 2021 - 2033 (USD Million)
  • Table 4 Global liquid biopsy for early cancer detection and monitoring market, By Cancer, 2021 - 2033 (USD Million)
  • Table 5 Global liquid biopsy for early cancer detection and monitoring market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 6 Global liquid biopsy for early cancer detection and monitoring market, By Technology, 2021 - 2033 (USD Million)
  • Table 7 Global liquid biopsy for early cancer detection and monitoring market, By End Use, 2021 - 2033 (USD Million)
  • Table 8 North America Liquid Biopsy for Early Cancer Detection and Monitoring Market, By Country, 2021 - 2033 (USD Million)
  • Table 9 North America Liquid Biopsy for Early Cancer Detection and Monitoring Market, By Cancer, 2021 - 2033 (USD Million)
  • Table 10 North America Liquid Biopsy for Early Cancer Detection and Monitoring Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 11 North America Liquid Biopsy for Early Cancer Detection and Monitoring Market, By Technology, 2021 - 2033 (USD Million)
  • Table 12 North America Liquid Biopsy for Early Cancer Detection and Monitoring Market, By End Use, 2021 - 2033 (USD Million)
  • Table 13 U.S. Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Cancer, 2021 - 2033 (USD Million)
  • Table 14 U.S. Liquid Biopsy for Early Cancer Detection and Monitoring Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 15 U.S. Liquid Biopsy for Early Cancer Detection and Monitoring Market, By Technology, 2021 - 2033 (USD Million)
  • Table 16 U.S. Liquid Biopsy for Early Cancer Detection and Monitoring Market, By End Use, 2021 - 2033 (USD Million)
  • Table 17 Canada Liquid Biopsy for Early Cancer Detection and Monitoring Market, By Cancer, 2021 - 2033 (USD Million)
  • Table 18 Canada Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Biomarker, 2021 - 2033 (USD Million)
  • Table 19 Canada Liquid Biopsy for Early Cancer Detection and Monitoring Market, by Technology, 2021 - 2033 (USD Million)
  • Table 20 Canada Liquid Biopsy for Early Cancer Detection and Monitoring Market, By End Use, 2021 - 2033 (USD Million)
  • Table 21 Mexico liquid biopsy for early cancer detection and monitoring market, by Cancer, 2021 - 2033 (USD Million)
  • Table 22 Mexico Liquid Biopsy for Early Cancer Detection and Monitoring Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 23 Mexico Liquid Biopsy for Early Cancer Detection and Monitoring Market, By Technology, 2021 - 2033 (USD Million)
  • Table 24 Mexico Liquid Biopsy for Early Cancer Detection and Monitoring Market, By End Use, 2021 - 2033 (USD Million)
  • Table 25 Europe liquid biopsy for early cancer detection and monitoring market, by country, 2021 - 2033 (USD Million)
  • Table 26 Europe liquid biopsy for early cancer detection and monitoring market, by Cancer, 2021 - 2033 (USD Million)
  • Table 27 Europe Liquid Biopsy for Early Cancer Detection and Monitoring Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 28 Europe Liquid Biopsy for Early Cancer Detection and Monitoring Market, By Technology, 2021 - 2033 (USD Million)
  • Table 29 Europe Liquid Biopsy for Early Cancer Detection and Monitoring Market, By End Use, 2021 - 2033 (USD Million)
  • Table 30 UK liquid biopsy for early cancer detection and monitoring market, by Cancer, 2021 - 2033 (USD Million)
  • Table 31 UK Liquid Biopsy for Early Cancer Detection and Monitoring Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 32 UK Liquid Biopsy for Early Cancer Detection and Monitoring Market, By Technology, 2021 - 2033 (USD Million)
  • Table 33 UK Liquid Biopsy for Early Cancer Detection and Monitoring Market, By End Use, 2021 - 2033 (USD Million)
  • Table 34 Germany liquid biopsy for early cancer detection and monitoring market, by Cancer, 2021 - 2033 (USD Million)
  • Table 35 Germany Liquid Biopsy for Early Cancer Detection and Monitoring Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 36 Germany Liquid Biopsy for Early Cancer Detection and Monitoring Market, By Technology, 2021 - 2033 (USD Million)
  • Table 37 Germany Liquid Biopsy for Early Cancer Detection and Monitoring Market, By End Use, 2021 - 2033 (USD Million)
  • Table 38 France liquid biopsy for early cancer detection and monitoring market, by Cancer, 2021 - 2033 (USD Million)
  • Table 39 France Liquid Biopsy for Early Cancer Detection and Monitoring Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 40 France Liquid Biopsy for Early Cancer Detection and Monitoring Market, By Technology, 2021 - 2033 (USD Million)
  • Table 41 France Liquid Biopsy for Early Cancer Detection and Monitoring Market, By End Use, 2021 - 2033 (USD Million)
  • Table 42 Italy liquid biopsy for early cancer detection and monitoring market, by Cancer, 2021 - 2033 (USD Million)
  • Table 43 Italy Liquid Biopsy for Early Cancer Detection and Monitoring Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 44 Italy Liquid Biopsy for Early Cancer Detection and Monitoring Market, By Technology, 2021 - 2033 (USD Million)
  • Table 45 Italy Liquid Biopsy for Early Cancer Detection and Monitoring Market, By End Use, 2021 - 2033 (USD Million)
  • Table 46 Spain liquid biopsy for early cancer detection and monitoring market, by Cancer, 2021 - 2033 (USD Million)
  • Table 47 Spain Liquid Biopsy for Early Cancer Detection and Monitoring Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 48 Spain Liquid Biopsy for Early Cancer Detection and Monitoring Market, By Technology, 2021 - 2033 (USD Million)
  • Table 49 Spain Liquid Biopsy for Early Cancer Detection and Monitoring Market, By End Use, 2021 - 2033 (USD Million)
  • Table 50 Sweden liquid biopsy for early cancer detection and monitoring market, by Cancer, 2021 - 2033 (USD Million)
  • Table 51 Sweden Liquid Biopsy for Early Cancer Detection and Monitoring Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 52 Sweden Liquid Biopsy for Early Cancer Detection and Monitoring Market, By Technology, 2021 - 2033 (USD Million)
  • Table 53 Sweden Liquid Biopsy for Early Cancer Detection and Monitoring Market, By End Use, 2021 - 2033 (USD Million)
  • Table 54 Norway liquid biopsy for early cancer detection and monitoring market, by Cancer, 2021 - 2033 (USD Million)
  • Table 55 Norway Liquid Biopsy for Early Cancer Detection and Monitoring Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 56 Norway Liquid Biopsy for Early Cancer Detection and Monitoring Market, By Technology, 2021 - 2033 (USD Million)
  • Table 57 Norway Liquid Biopsy for Early Cancer Detection and Monitoring Market, By End Use, 2021 - 2033 (USD Million)
  • Table 58 Denmark liquid biopsy for early cancer detection and monitoring market, by Cancer, 2021 - 2033 (USD Million)
  • Table 59 Denmark Liquid Biopsy for Early Cancer Detection and Monitoring Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 60 Denmark Liquid Biopsy for Early Cancer Detection and Monitoring Market, By Technology, 2021 - 2033 (USD Million)
  • Table 61 Denmark Liquid Biopsy for Early Cancer Detection and Monitoring Market, By End Use, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific liquid biopsy for early cancer detection and monitoring market, by country, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific liquid biopsy for early cancer detection and monitoring market, by Cancer, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific Liquid Biopsy for Early Cancer Detection and Monitoring Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific Liquid Biopsy for Early Cancer Detection and Monitoring Market, By Technology, 2021 - 2033 (USD Million)
  • Table 66 Asia Pacific Liquid Biopsy for Early Cancer Detection and Monitoring Market, By End Use, 2021 - 2033 (USD Million)
  • Table 67 Japan liquid biopsy for early cancer detection and monitoring market, by Cancer, 2021 - 2033 (USD Million)
  • Table 68 Japan Liquid Biopsy for Early Cancer Detection and Monitoring Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 69 Japan Liquid Biopsy for Early Cancer Detection and Monitoring Market, By Technology, 2021 - 2033 (USD Million)
  • Table 70 Japan Liquid Biopsy for Early Cancer Detection and Monitoring Market, By End Use, 2021 - 2033 (USD Million)
  • Table 71 China liquid biopsy for early cancer detection and monitoring market, by Cancer, 2021 - 2033 (USD Million)
  • Table 72 China liquid biopsy for early cancer detection and monitoring market, by Biomarker, 2021 - 2033 (USD Million)
  • Table 73 China liquid biopsy for early cancer detection and monitoring market, by Technology, 2021 - 2033 (USD Million)
  • Table 74 China liquid biopsy for early cancer detection and monitoring market, by End Use, 2021 - 2033 (USD Million)
  • Table 75 India liquid biopsy for early cancer detection and monitoring market, by Cancer, 2021 - 2033 (USD Million)
  • Table 76 India liquid biopsy for early cancer detection and monitoring market, by Biomarker, 2021 - 2033 (USD Million)
  • Table 77 India liquid biopsy for early cancer detection and monitoring market, by Technology, 2021 - 2033 (USD Million)
  • Table 78 India liquid biopsy for early cancer detection and monitoring market, by End Use, 2021 - 2033 (USD Million)
  • Table 79 Australia liquid biopsy for early cancer detection and monitoring market, by Cancer, 2021 - 2033 (USD Million)
  • Table 80 Australia liquid biopsy for early cancer detection and monitoring market, by Biomarker, 2021 - 2033 (USD Million)
  • Table 81 Australia liquid biopsy for early cancer detection and monitoring market, by Technology, 2021 - 2033 (USD Million)
  • Table 82 Australia liquid biopsy for early cancer detection and monitoring market, by End Use, 2021 - 2033 (USD Million)
  • Table 83 Thailand liquid biopsy for early cancer detection and monitoring market, by Cancer, 2021 - 2033 (USD Million)
  • Table 84 Thailand liquid biopsy for early cancer detection and monitoring market, by Biomarker, 2021 - 2033 (USD Million)
  • Table 85 Thailand liquid biopsy for early cancer detection and monitoring market, by Technology, 2021 - 2033 (USD Million)
  • Table 86 Thailand liquid biopsy for early cancer detection and monitoring market, by End Use, 2021 - 2033 (USD Million)
  • Table 87 South Korea liquid biopsy for early cancer detection and monitoring market, by Cancer, 2021 - 2033 (USD Million)
  • Table 88 South Korea liquid biopsy for early cancer detection and monitoring market, by Biomarker, 2021 - 2033 (USD Million)
  • Table 89 South Korea liquid biopsy for early cancer detection and monitoring market, by Technology, 2021 - 2033 (USD Million)
  • Table 90 South Korea liquid biopsy for early cancer detection and monitoring market, by End Use, 2021 - 2033 (USD Million)
  • Table 91 Latin America liquid biopsy for early cancer detection and monitoring market, by country, 2021 - 2033 (USD Million)
  • Table 92 Latin America liquid biopsy for early cancer detection and monitoring market, by Cancer, 2021 - 2033 (USD Million)
  • Table 93 Latin America liquid biopsy for early cancer detection and monitoring market, by Biomarker, 2021 - 2033 (USD Million)
  • Table 94 Latin America liquid biopsy for early cancer detection and monitoring market, by Technology, 2021 - 2033 (USD Million)
  • Table 95 Latin America liquid biopsy for early cancer detection and monitoring market, by End Use, 2021 - 2033 (USD Million)
  • Table 96 Brazil liquid biopsy for early cancer detection and monitoring market, by Cancer, 2021 - 2033 (USD Million)
  • Table 97 Brazil liquid biopsy for early cancer detection and monitoring market, by Biomarker, 2021 - 2033 (USD Million)
  • Table 98 Brazil liquid biopsy for early cancer detection and monitoring market, by Technology, 2021 - 2033 (USD Million)
  • Table 99 Brazil liquid biopsy for early cancer detection and monitoring market, by End Use, 2021 - 2033 (USD Million)
  • Table 100 Argentina liquid biopsy for early cancer detection and monitoring market, by Cancer, 2021 - 2033 (USD Million)
  • Table 101 Argentina liquid biopsy for early cancer detection and monitoring market, by Biomarker, 2021 - 2033 (USD Million)
  • Table 102 Argentina liquid biopsy for early cancer detection and monitoring market, by Technology, 2021 - 2033 (USD Million)
  • Table 103 Argentina liquid biopsy for early cancer detection and monitoring market, by End Use, 2021 - 2033 (USD Million)
  • Table 104 MEA liquid biopsy for early cancer detection and monitoring market, by country, 2021 - 2033 (USD Million)
  • Table 105 MEA liquid biopsy for early cancer detection and monitoring market, by Cancer, 2021 - 2033 (USD Million)
  • Table 106 MEA liquid biopsy for early cancer detection and monitoring market, by Biomarker, 2021 - 2033 (USD Million)
  • Table 107 MEA liquid biopsy for early cancer detection and monitoring market, by Technology, 2021 - 2033 (USD Million)
  • Table 108 MEA liquid biopsy for early cancer detection and monitoring market, by End Use, 2021 - 2033 (USD Million)
  • Table 109 South Africa liquid biopsy for early cancer detection and monitoring market, by Cancer, 2021 - 2033 (USD Million)
  • Table 110 South Africa liquid biopsy for early cancer detection and monitoring market, by Biomarker, 2021 - 2033 (USD Million)
  • Table 111 South Africa liquid biopsy for early cancer detection and monitoring market, by Technology, 2021 - 2033 (USD Million)
  • Table 112 South Africa liquid biopsy for early cancer detection and monitoring market, by End Use, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia liquid biopsy for early cancer detection and monitoring market, by Cancer, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia liquid biopsy for early cancer detection and monitoring market, by Biomarker, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia liquid biopsy for early cancer detection and monitoring market, by Technology, 2021 - 2033 (USD Million)
  • Table 116 Saudi Arabia liquid biopsy for early cancer detection and monitoring market, by End Use, 2021 - 2033 (USD Million)
  • Table 117 UAE liquid biopsy for early cancer detection and monitoring market, by Cancer, 2021 - 2033 (USD Million)
  • Table 118 UAE liquid biopsy for early cancer detection and monitoring market, by Biomarker, 2021 - 2033 (USD Million)
  • Table 119 UAE liquid biopsy for early cancer detection and monitoring market, by Technology, 2021 - 2033 (USD Million)
  • Table 120 UAE liquid biopsy for early cancer detection and monitoring market, by End Use, 2021 - 2033 (USD Million)
  • Table 121 Kuwait liquid biopsy for early cancer detection and monitoring market, by Cancer, 2021 - 2033 (USD)
  • Table 122 Kuwait liquid biopsy for early cancer detection and monitoring market, by Biomarker, 2021 - 2033 (USD Million)
  • Table 123 Kuwait liquid biopsy for early cancer detection and monitoring market, by Technology, 2021 - 2033 (USD Million)
  • Table 124 Kuwait liquid biopsy for early cancer detection and monitoring market, by End Use, 32021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Global liquid biopsy for early cancer detection and monitoring market- Key market driver analysis
  • Fig. 7 Global liquid biopsy for early cancer detection and monitoring market- Key market restraint analysis
  • Fig. 8 Penetration & growth prospect mapping
  • Fig. 9 Global liquid biopsy for early cancer detection and monitoring market- Porter's analysis
  • Fig. 10 Global liquid biopsy for early cancer detection and monitoring market- PESTEL analysis
  • Fig. 11 Global liquid biopsy for early cancer detection and monitoring marketbiomarker outlook key takeaways
  • Fig. 12 Global liquid biopsy for early cancer detection and monitoring market: biomarker movement analysis
  • Fig. 13 Circulating Tumor DNA (ctDNA) market estimates, 2021 - 2033 (USD Million)
  • Fig. 14 Circulating Tumor Cells (CTCs) market estimates, 2021 - 2033 (USD Million)
  • Fig. 15 Exosomes/Microvesicles market estimates, 2021 - 2033 (USD Million)
  • Fig. 16 Circulating Proteins market estimates, 2021 - 2033 (USD Million)
  • Fig. 17 Global liquid biopsy for early cancer detection and monitoring markettechnology outlook key takeaways
  • Fig. 18 Global liquid biopsy for early cancer detection and monitoring market: technology movement analysis
  • Fig. 19 NGS (Next-Generation Sequencing) market estimates, 2021 - 2033 (USD Million)
  • Fig. 20 PCR-based assays (Digital PCR, RT-PCR) market estimates, 2021 - 2033 (USD Million)
  • Fig. 21 Microarray market estimates, 2021 - 2033 (USD Million)
  • Fig. 22 Epigenomics / Methylation assays market estimates, 2021 - 2033 (USD Million)
  • Fig. 23 Others market estimates, 2021 - 2033 (USD Million)
  • Fig. 24 Global liquid biopsy for early cancer detection and monitoring marketcancer outlook key takeaways
  • Fig. 25 Global liquid biopsy for early cancer detection and monitoring market: cancer movement analysis
  • Fig. 26 Lung cancer market estimates, 2021 - 2033 (USD Million)
  • Fig. 27 Breast cancer market estimates, 2021 - 2033 (USD Million)
  • Fig. 28 Colorectal cancer market estimates, 2021 - 2033 (USD Million)
  • Fig. 29 Prostate cancer market estimates, 2021 - 2033 (USD Million)
  • Fig. 30 Others market estimates, 2021 - 2033 (USD Million)
  • Fig. 31 Global liquid biopsy for early cancer detection and monitoring marketend use outlook key takeaways
  • Fig. 32 Global liquid biopsy for early cancer detection and monitoring market: end use movement analysis
  • Fig. 33 Hospitals market estimates, 2021 - 2033 (USD Million)
  • Fig. 34 Diagnostic Laboratories market estimates, 2021 - 2033 (USD Million)
  • Fig. 35 Others market estimates, 2021 - 2033 (USD Million)
  • Fig. 36 Regional marketplace: Key takeaways
  • Fig. 37 Global liquid biopsy for early cancer detection and monitoring market: Regional movement analysis
  • Fig. 38 North America liquid biopsy for early cancer detection and monitoring market, 2021 - 2033 (USD Million)
  • Fig. 39 U.S. liquid biopsy for early cancer detection and monitoring market, 2021 - 2033 (USD Million)
  • Fig. 40 Canada liquid biopsy for early cancer detection and monitoring market, 2021 - 2033 (USD Million)
  • Fig. 41 Mexico liquid biopsy for early cancer detection and monitoring market, 2021 - 2033 (USD Million)
  • Fig. 42 Europe liquid biopsy for early cancer detection and monitoring market, 2021 - 2033 (USD Million)
  • Fig. 43 UK liquid biopsy for early cancer detection and monitoring market, 2021 - 2033 (USD Million)
  • Fig. 44 Germany liquid biopsy for early cancer detection and monitoring market, 2021 - 2033 (USD Million)
  • Fig. 45 France liquid biopsy for early cancer detection and monitoring market, 2021 - 2033 (USD Million)
  • Fig. 46 Spain liquid biopsy for early cancer detection and monitoring market, 2021 - 2033 (USD Million)
  • Fig. 47 Italy liquid biopsy for early cancer detection and monitoring market, 2021 - 2033 (USD Million)
  • Fig. 48 Denmark liquid biopsy for early cancer detection and monitoring market, 2021 - 2033 (USD Million)
  • Fig. 49 Sweden liquid biopsy for early cancer detection and monitoring market, 2021 - 2033 (USD Million)
  • Fig. 50 Norway liquid biopsy for early cancer detection and monitoring market, 2021 - 2033 (USD Million)
  • Fig. 51 Asia Pacific liquid biopsy for early cancer detection and monitoring market, 2021 - 2033 (USD Million)
  • Fig. 52 Japan liquid biopsy for early cancer detection and monitoring market, 2021 - 2033 (USD Million)
  • Fig. 53 China liquid biopsy for early cancer detection and monitoring market, 2021 - 2033 (USD Million)
  • Fig. 54 India liquid biopsy for early cancer detection and monitoring market, 2021 - 2033 (USD Million)
  • Fig. 55 South Korea liquid biopsy for early cancer detection and monitoring market, 2021 - 2033 (USD Million)
  • Fig. 56 Australia liquid biopsy for early cancer detection and monitoring market, 2021 - 2033 (USD Million)
  • Fig. 57 Thailand liquid biopsy for early cancer detection and monitoring market, 2021 - 2033 (USD Million)
  • Fig. 58 Latin America liquid biopsy for early cancer detection and monitoring market, 2021 - 2033 (USD Million)
  • Fig. 59 Brazil liquid biopsy for early cancer detection and monitoring market, 2021 - 2033 (USD Million)
  • Fig. 60 Argentina liquid biopsy for early cancer detection and monitoring market, 2021 - 2033 (USD Million)
  • Fig. 61 MEA liquid biopsy for early cancer detection and monitoring market, 2021 - 2033 (USD Million)
  • Fig. 62 South Africa liquid biopsy for early cancer detection and monitoring market, 2021 - 2033 (USD Million)
  • Fig. 63 Saudi Arabia liquid biopsy for early cancer detection and monitoring market, 2021 - 2033 (USD Million)
  • Fig. 64 UAE liquid biopsy for early cancer detection and monitoring market, 2021 - 2033 (USD Million)
  • Fig. 65 Kuwait liquid biopsy for early cancer detection and monitoring market, 2021 - 2033 (USD Million)
  • Fig. 66 Strategy framework